← Back to Clinical Trials
Recruiting NCT06409559

NCT06409559 Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06409559
Status Recruiting
Phase
Sponsor University of Cincinnati
Condition Acetabular Fracture
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-08-01
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Pelvic reconstruction plate without interfragmentary screwsPelvic reconstruction plate with interfragmentary screws

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-08-01 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The hypothesis of this study is that the Rim Plate method utilizing interfragmentary screws placed through the plate will result in superior fixation, a lower rate of loss of reduction of the fracture fragment, better anatomic healing of the articular (joint) surface, a decreased rate of early post-traumatic arthritic changes of the joint (cartilage) surface, and improved functional outcomes.

Eligibility Criteria

Inclusion Criteria: 1. Skeletally mature males and females, ≥ 18 years old and with age less than 65 years. 2. Fracture of the acetabular posterior wall fracture due to acute traumatic hip dislocation, confirmed with anteroposterior pelvic or hip radiographs, and CT scan 3. Operative fixation of fractures within 14 days of presenting to the emergency room. 4. Patient was ambulatory prior to fracture, with or without walking aids 5. Medically optimized for operative intervention 6. Provision of informed consent by patient or legal guardian. Exclusion Criteria: 1. Patients not suitable for internal fixation (severe osteoarthritis, rheumatoid arthritis, or pathologic fracture). 2. Pre-existing orthopedic fixation, implant, or prosthesis around the affected acetabulum. 3. Patients with metabolic bone disease including diagnosis of osteoporosis. 4. Patients with bony or soft tissue infections around the acetabulum. 5. Patients unable to provide informed consent. 6. Patients having other fractures of Pelvis or acetabulum other than an isolated posterior acetabular wall fracture. 7. Patients with previous history of acetabular fracture (operative or nonoperative) 8. Patients with previous history of hip pathology such as avascular necrosis, hip dysplasia, Legg-Calve Perthes Disease, or advanced degenerative arthritis.

Contact & Investigator

Central Contact

Kimberly A Hasselfeld

✉ hasselky@uc.edu

📞 5135581933

Frequently Asked Questions

Who can join the NCT06409559 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acetabular Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06409559 currently recruiting?

Yes, NCT06409559 is actively recruiting participants. Contact the research team at hasselky@uc.edu for enrollment information.

Where is the NCT06409559 trial being conducted?

This trial is being conducted at Cincinnati, United States.

Who is sponsoring the NCT06409559 clinical trial?

NCT06409559 is sponsored by University of Cincinnati. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology